Tag: Noveome Biotherapeutics

October 24, 2019 Off

Noveome Biotherapeutics appoints Kevin E. McCracken as Senior Vice President of Operations

PITTSBURGH–(BUSINESS WIRE)–Noveome Biotherapeutics, Inc., a clinical-stage biopharmaceutical company focused on developing next-generation biologics for the promotion and restoration of cellular…

September 26, 2019 Off

Noveome Biotherapeutics kicks off phase 1 clinical trial of its ST266 for the optic nerve and brain

By BusinessWire

Nevome Biotherapeutics has started testing its ST266 when delivered intranasally in a Phase 1 open label clinical trial, in patients diagnosed with intraocular hypertension who have not yet developed optic nerve damage, with topline results expected by end of the second quarter of 2020.